296 related articles for article (PubMed ID: 19646646)
21. Acquired Bleeding Disorders.
Hurwitz A; Massone R; Lopez BL
Hematol Oncol Clin North Am; 2017 Dec; 31(6):1123-1145. PubMed ID: 29078927
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes.
Mannucci PM; Franchini M
Eur J Intern Med; 2010 Aug; 21(4):254-9. PubMed ID: 20603031
[TBL] [Abstract][Full Text] [Related]
24. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
25. Management of abnormal uterine bleeding in adolescents.
Wilkinson JP; Kadir RA
J Pediatr Adolesc Gynecol; 2010 Dec; 23(6 Suppl):S22-30. PubMed ID: 20869283
[No Abstract] [Full Text] [Related]
26. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
[TBL] [Abstract][Full Text] [Related]
27. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Tobias JD; Berkenbosch JW
Clin Pediatr (Phila); 2002 Oct; 41(8):613-6. PubMed ID: 12403380
[No Abstract] [Full Text] [Related]
28. [Haemostaseological aspects of perioperative blood management].
Scherer RU
Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
[TBL] [Abstract][Full Text] [Related]
29. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
Bauzá G; Hirsch E; Burke P; Quillen K
Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
[No Abstract] [Full Text] [Related]
30. Acquired bleeding disorders.
Hurwitz A; Massone R; Lopez BL
Emerg Med Clin North Am; 2014 Aug; 32(3):691-713. PubMed ID: 25060257
[TBL] [Abstract][Full Text] [Related]
31. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
Chuansumrit A; Treepongkaruna S; Phuapradit P
Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
[No Abstract] [Full Text] [Related]
32. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
33. Recommendations for the management of trauma or surgery-related massive blood loss.
Paluszkiewicz P; Mayzner-Zawadzka E; Baranowski W; Bręborowicz GH; Brzeziński M; Durek G; Dziki A; Czupryńska MM; Lipińska-Gediga M; Lętowska M; Mital A; Nowacka E; Pychyńska-Pokorska M; Ratajczak J; Rogowski J; Rybicki Z; Sobieszczyk S; Trzciński R; Wawrzynowicz-Syczewska M; Windyga J; Wujtewicz M;
Pol Przegl Chir; 2011 Aug; 83(8):465-76. PubMed ID: 22166722
[TBL] [Abstract][Full Text] [Related]
34. [Provision for hemostasis in surgery].
Filatov AN
Khirurgiia (Mosk); 1974 Jun; (6):48-52. PubMed ID: 4281845
[No Abstract] [Full Text] [Related]
35. Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness.
Culligan DJ; Salamat A; Tait J; Westland G; Watson HG
Bone Marrow Transplant; 2003 Jun; 31(12):1183-4. PubMed ID: 12796803
[No Abstract] [Full Text] [Related]
36. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative management of coagulation.
Clevenger B; Mallett SV
Br J Hosp Med (Lond); 2014 May; 75 Suppl 5():C76-9. PubMed ID: 25075414
[No Abstract] [Full Text] [Related]
38. Perioperative hemostatic management in the cirrhotic patient: a position paper on behalf of the Liver Intensive Care Group of Europe (LICAGE).
Biancofiore G; Blasi A; De Boer MT; Franchini M; Hartmann M; Lisman T; Liumbruno GM; Porte RJ; Saner F; Senzolo M; Werner MJ
Minerva Anestesiol; 2019 Jul; 85(7):782-798. PubMed ID: 30945514
[TBL] [Abstract][Full Text] [Related]
39. [Coagulation factor XIII – Pathophysiology, clinic and therapy of factor XIII deficiency].
Weber CF; Adam EH; Pape A; Jöst M; Meybohm P; Schmitz K; Zacharowski K; Hermann M; Fries D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2015 Nov; 50(11-12):684-90. PubMed ID: 26650946
[TBL] [Abstract][Full Text] [Related]
40. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
Bartal C; Freedman J; Bowman K; Cusimano M
J Trauma; 2007 Oct; 63(4):725-32. PubMed ID: 18089997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
